Molinare Tames Workflow Complexity with Ngenea® Software From pixitmedia, a Kalray Company
By minimizing complexity, Molinare deploys Ngenea to gain efficiency and remove barriers to expansion; effective storage frees teams to innovate, boost creativity, and push the boundaries of post-production
pixitmedia, a subsidiary of Kalray (Euronext Growth Paris: ALKAL) specializing in storage and data management solutions for the media & entertainment industry, announced that it assisted legendary UK post-production firm Molinare in taming production workflow complexity by deploying Ngenea®, pixitmedia’s flagship data acceleration platform. With Ngenea as the centerpiece of its technology infrastructure, Molinare is unlocking new realms of creativity in long-form production.
pixitmedia will showcase Molinare’s deployment and its innovative data storage solution at IBC 2024 Amsterdam, September 13 – 16, in Hall 5.H79.
“pixitmedia has so massively improved how our systems work together, with added reliability and new powers to handle complex, high-resolution projects to extremely tight deadlines,” said Darren Woolfson, chief technology officer of Molinare. “Backed by the infrastructure that pixitmedia helped us build around its Ngenea software, we gained control over our workflows and can continue to exceed client expectations well into the future.”
Founded in 1973 and now the largest independent post-production house in the United Kingdom, Molinare specializes in long-form content and end-to-end finishing services for major clients like Netflix and the BBC, on award-winning titles such as Peaky Blinders, Sexy Beast and Beckham. The company built its reputation on creative excellence born out of delivering high-quality work, quickly. As business grew, Molinare’s 15 high-end digital grading and finishing suites for AutoDesk Flame and Filmlight BaseLight work became even busier with high-framerate 4K projects. The workflow required passing content from one station to the next, leading to a proliferation of copies, and major strain on the infrastructure. With instances of operator frustration on the rise, Molinare saw an opportunity for a change.
Together pixitmedia and Molinare designed and delivered a unified central storage solution built around pixitmedia’s Ngenea intelligent tiering system for optimized media placement.
"Fast storage can provide the level of raw performance for video to play back, but we needed even more - including a storage solution that could deliver all levels of performance required to underpin our entire operation," Woolfson continued. "With Ngenea, our team now can routinely handle complex, high-resolution projects without bottlenecks or delays. We know we can meet even the tightest of deadlines, and continue to exceed client expectations, " Woolfson said.
Molinare’s enhanced infrastructure uses Ngenea to consolidate storage islands, creating a cohesive ecosystem via an intelligent tiering system where media was readily available. A leading data acceleration platform for M&E professionals, Ngenea enables customers to accelerate the processing of their data and to streamline complex workflows. Ngenea's single namespace provided transparency and file access across storage tiers and remote locations, enhancing flexibility for global expansion. In addition to Ngenea, Molinare’s unified central storage solution includes Nvidia Mellanox backend networking for seamless data flow ; Seagate NL-SAS storage for additional capacity ; and lightning-fast NVMe storage for Molinare’s Flame stations and high-speed online work. This approach gave Molinare transparent file access across storage tiers and remote locations, reducing scheduling conflicts and enhancing workflow efficiency. As a result, Molinare improved its infrastructure reliability, eliminated bottlenecks, and gaining control of their complex and data intensive workflows, setting the stage for future growth and innovation.
As Molinare team members moved more projects to the new system, longstanding scheduling conflicts disappeared. With technical hurdles cleared, Molinare found new time to innovate and push creative boundaries. The company launched Molinare Creative Group, a collective of 5 specialized brands, and is expanding into new markets with facilities planned in Malta and Liverpool. They're also exploring short-form digital content to reach wider audiences.
“Technology sets the stage for business success, and we are delighted that our sister company pixitmedia, leveraging our Ngenea data acceleration platform, has been able to help Molinare take its business to the next level,” said Eric Baissus, CEO of Kalray, parent to pixitmedia.
ABOUT KALRAY
Kalray is a technology innovator specializing in software and hardware solutions to accelerate data-intensive workflows in Media & Entertainment, High-Performance Computing, and Artificial Intelligence. Our comprehensive product range features Ngenea, a leading data acceleration platform, and accelerated data processing cards for storage and compute.
With Kalray solutions, customers can scale their infrastructures to efficiently meet performance and capacity needs for data-intensive tasks, all without being tied to specific data formats or vendors.
Founded in 2008 as a spin-off from the French CEA research lab, Kalray has corporate and financial backing from notable investors such as Alliance Venture (Renault-Nissan-Mitsubishi), NXP Semiconductors, and Bpifrance. Committed to innovation and excellence, we strive to deliver value to our customers, developers, and the planet through technology and expertise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905373077/en/
Contacts
INVESTOREric BAISSUS
INVESTOREric BAISSUS
contactinvestisseurs@kalrayinc.com
Phone +33 4 76 18 90 71
ACTUS Finance & Communication
Anne-Pauline PETUREAUX
kalray@actus.fr
Phone + 33 1 53 67 36 72
PRESSPenta STANLEY
communication@kalrayinc.com
Phone +44 7939 877 880
ACTUS Finance & Communication
Serena BONI
sboni@actus.fr
Phone +33 4 72 18 04 92
Mary Kae MARINAC
PR Representative for Kalray
mk@mkmarinac.com
Phone +1 978-685-3136
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
Perma-Pipe International Holdings, Inc. Announces Third Quarter Financial Results23.12.2024 18:43:00 CET | Press release
The Company generated net sales of $41.6 million for the quarter and $113.4 million year-to-dateIncome before income taxes of $5.1 million for the quarter and $13.2 million year-to-dateBacklog of $114.2 million at October 31, 2024, compared to $68.5 million at January 31, 2024 Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the second quarter and fiscal year-to-date period ended October 31, 2024. "Net sales for the third quarter were $41.6 million, a decrease of $4.1 million, as compared to the same quarter last year. Net income attributable to common stock of $2.5 million was an increase of $0.5 million, or 29%, compared to $1.9 million in the third quarter of 2023. For the nine months ended October 31, 2024, net sales of $113.4 million represent an increase of 3% compared to the nine months ended October 31, 2023. The net income attributable to common stock of $7.2 million was an increase of $5.4 million, or 294%, compared to net income at
LambdaTest Unveils Next-Generation SmartUI Experience for Visual Testing23.12.2024 17:00:00 CET | Press release
LambdaTest unveils its redesigned SmartUI experience, transforming visual testing with seamless navigation, precise controls, and enhanced workflows. LambdaTest, a leading cloud-based unified testing platform has announced the general availability of its reimagined SmartUI screenshot page. This new update is all set to transform visual testing workflows, delivering a seamless, intuitive, and powerful experience tailored to the needs of testers and developers worldwide. The redesigned SmartUI interface introduces groundbreaking enhancements that prioritize user efficiency and precision. From the new pinch-to-zoom functionality for precise screenshot inspection to a streamlined navigation system featuring a side drawer for quick browsing, every detail has been thoughtfully crafted to improve productivity. The refreshed design also offers a cleaner, more spacious layout, ensuring that users can focus on what matters most—their screenshots. Smarter workflows now empower users with an intui
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases23.12.2024 13:00:00 CET | Press release
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa; Head Office: Minato-ku, Tokyo), a wholly-owned subsidiary of H.U. Group Holdings, Inc. (Chairman, President and Group CEO: Shigekazu Takeuchi; Head Office: Minato-ku, Tokyo), and Eisai Co., Ltd. (Representative Corporate Officer and CEO: Haruo Naito; Head Office: Bunkyo-ku, Tokyo; hereinafter "Eisai") announced today that they have entered into a memorandum of understanding for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases. Fujirebio and Eisai have been conducting joint research on cerebrospinal fluid biomarkers related to Alzheimer’s disease (AD). The two companies have agreed to move forward with their partnership based on the shared understanding that the development and commercialization of diagnostic methods for neurodegenerative diseases can be accelerated by integrating the long-standing respective expertise of Fujirebio, which has experience in the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom